Physician profile
Jonathan H Lerner
NPI 1962899823
$30,284.86
in general payments reported to CMS, 2019-2025
40 companies · $4,700 in 2025
The $4,700 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,541 · 2020: $655 · 2021: $2,648 · 2022: $5,441 · 2023: $7,075 · 2024: $8,226 · 2025: $4,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $5,109 · Consulting Fee: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,766.63 |
| Travel and Lodging | $5,108.66 |
| Consulting Fee | $1,125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,399.10 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic, INC. | $6,627.43 | 2021-2025 | Micra, Selectsecure, Linq II |
| Boston Scientific Corporation | $5,954.37 | 2019-2025 | Farapulse, Emblem Mri S-Icd, S-Icd System Magnet |
| Biosense Webster, INC. | $2,979.38 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Medical Device Business Services, INC. | $1,196.36 | 2021-2024 | Carto 3 |
| Cardiva Medical, INC. | $1,040.40 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Optowire |
| Biotronik INC. | $734.79 | 2022-2024 | Acticor 7 Vr-T Dx, Pamira, Solia |
| Janssen Pharmaceuticals, INC | $666.37 | 2019-2024 | Xarelto |
| Abiomed | $505.11 | 2019-2021 | |
| Cook Medical LLC | $466.02 | 2022-2023 | Evolution |
| Cook Incorporated | $444.13 | 2022 | |
| Edwards Lifesciences Corporation | $367.37 | 2023-2025 | Sapien 3 Ultra Resilia |
| Heartflow, INC. | $276.13 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $266.33 | 2019-2025 | Lifevest |
| Amgen INC. | $207.68 | 2019-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.